About Drug Development Biometric Services Market
The global drug development biometric services market deals with data management and statistical analysis services that are required in clinical trials for drug research and discovery. Most drug researchers and developers do not exhibit the competency to manage clinical trial data effectively, creating demand for drug development biometric service providers. Moreover, these service providers simplify processes such as data collection, validation, and analysis for buyers as well as provide a much critical service of ensuring clinical data security. Thus, these suppliers ensure high conformance to regulations and standardization norms such as GDPR and GCPs.
Covered in this report
The report provides actionable insights to improve source-to-contract cycle performance in the Global Drug Development Biometric Services Market. It helps sourcing professionals formulate better category strategies, enhance savings, understand supplier and market challenges, and implement sourcing best practices.
The report, Global Drug Development Biometric Services Market, provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.
Category drivers
Category constraints
Procurement best practices
Key questions answered in this report
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
The global drug development biometric services market deals with data management and statistical analysis services that are required in clinical trials for drug research and discovery. Most drug researchers and developers do not exhibit the competency to manage clinical trial data effectively, creating demand for drug development biometric service providers. Moreover, these service providers simplify processes such as data collection, validation, and analysis for buyers as well as provide a much critical service of ensuring clinical data security. Thus, these suppliers ensure high conformance to regulations and standardization norms such as GDPR and GCPs.
Covered in this report
The report provides actionable insights to improve source-to-contract cycle performance in the Global Drug Development Biometric Services Market. It helps sourcing professionals formulate better category strategies, enhance savings, understand supplier and market challenges, and implement sourcing best practices.
The report, Global Drug Development Biometric Services Market, provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.
Category drivers
- The focus on cost reduction by pharmaceutical drug manufacturers and researchers
- For a full, detailed list, view our report
Category constraints
- Maintaining compatibility of solutions with the type of data collected in clinical trials
- For a full, detailed list, view our report
Procurement best practices
- Establishing data security and integrity protocols
- For a full, detailed list, view our report
Key questions answered in this report
- What are the market dynamics?
- What are the key market trends?
- What are the category growth drivers?
- What are the constraints to category growth?
- Who are the suppliers in this market?
- What are the demand-supply shifts?
- What are the major category requirements?
- What are the procurement best practices in this market?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 1: CATEGORY AT A GLANCE- TAKEAWAY 01 - Market Overview
- TAKEAWAY 02 - Demand and Supply Snapshot
- TAKEAWAY 03 - Key Market Dynamics
- TAKEAWAY 04 - Supply Market Highlights
- TAKEAWAY 05 - Pricing Insights
- TAKEAWAY 06 - Procurement Insights
PART 2: SCOPE OF THE REPORT
- Category Definition
- Research Methodology
PART 3: MARKET INSIGHTS
- Category Spend Analysis
- Category Maturity by Regions
- Demand-Supply Shifts
- Regional Demand-Supply Snapshot
- Market Developments
- Regional Impact of Trends
- Key Category Growth Drivers and Corresponding Regional Impacts
- Major Category Growth Constraints and Corresponding Regional Impacts
- Key Current Technological Innovations
- Major Regulatory Frameworks
- Strategic Sustainability Practices
- Porter’s Five Forces
- PESTLE Analysis
PART 4: SUPPLY MARKET INSIGHTS
- Supplier Operational Capability Matrix
- Other Prominent Suppliers by Region: Operational Capability Matrix
- Supplier Functional Capability Matrix
- Other Prominent Suppliers by Region: Functional Capability Matrix
- Key Clients and Partners
- Supplier Cost Breakup
- Supplier Positioning Matrix
PART 5: PRICING INSIGHTS
- Pricing Models Snapshot
- Pricing Models - Pros and Cons
- Indicative Wages
- Indicative Pricing
PART 6: PROCUREMENT INSIGHTS
- Major Category Requirements
- Major Procurement Pain Points
- Category Sourcing Evolution Matrix
- Procurement Best Practices
- Cost-saving Opportunities
- Supplier Selection Criteria
- Category Negotiation Strategies
- SLA Terms
- Supplier Evaluation Criteria
- Category Risk Analysis
PART 7: TOP FIVE SUPPLIERS
- PAREXEL
- Covance
- AbbVie
- IQVIA
- PPD
PART 8: APPENDIX
- Glossary
- Key Notes
Executive Summary
New Report Released: Global Drug Development Biometric Services Category - Procurement Market Intelligence Report 2018-2022.The author of the report recognizes the following companies as the key suppliers in the Global Drug Development Biometric Services Category - Procurement Market Intelligence Report: PAREXEL, Covance, AbbVie, IQVIA, and PPD.
Commenting on the report, an analyst from the research team said: “One of the best procurement practices for the buyers is to establish data security and integrity protocols.”
According to the report, one of the key growth contributors for the global drug development biometric services market is an increase in data security by regulators. Drug researchers and developers are subjected to regulations that aim to establish protocols for the protection of the data, which is collected during a drug development process.
Further, the report states that major procurement challenge experienced by the buyers is the need for clinical trial process re-engineering.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains actionable insights to improve source-to-contract cycle performance in addition to a PESTLE analysis.
Companies Mentioned
- PAREXEL
- Covance
- AbbVie
- IQVIA
- PPD
Methodology
LOADING...
